LAROSA JOSEPH J, GC, reported a transaction classified as withholding at REGENERON PHARMACEUTICALS, INC. involving 24493.000000 shares for an estimated $22344963.90. Reported holdings after the transaction were 39543.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
Form 4 relationship flags and nearby filing context
EVP General Counsel and Secret
The stock option award vests in four equal annual installments, commencing one year after the date of grant.
0 other filings
0 recent txs